Clorox (CLX) Capital Expenditures (2009 - 2026)

Clorox's Capital Expenditures history runs 17 years deep, the most recent figure standing at $43.0 million for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 18.87% year-over-year to $43.0 million in Q1 2026; TTM through Mar 2026 was $196.0 million, a 13.27% decrease from a year earlier, with the FY2025 full-year figure at $220.0 million, up 3.77% from the prior year.
• Capital Expenditures grew to $43.0 million in Q1 2026 per CLX's latest filing, from $42.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $84.0 million in Q2 2023 and bottomed at $24.0 million in Q3 2023.
• The 5-year median for Capital Expenditures is $53.0 million (2024), against an average of $54.3 million.
• Across the five-year window, Capital Expenditures sank 47.83% in 2023 and soared 62.5% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at $42.0 million in 2022, then advanced by 23.81% to $52.0 million in 2023, then climbed by 1.92% to $53.0 million in 2024, then dropped by 20.75% to $42.0 million in 2025, then climbed by 2.38% to $43.0 million in 2026.
• Per Business Quant, the three latest CLX Capital Expenditures figures stand at $43.0 million (Q1 2026), $42.0 million (Q4 2025), and $36.0 million (Q3 2025).